The new PhenoImager Fusion system brings the latest advances in multiplex imaging enabling whole-slide, multispectral imaging (MSI) at single-cell resolution at unprecedented speed (6 biomarkers per slide in under 20 minutes). Together with our high-throughput PhenoImager HT, these instruments are the fastest quantitative digital pathology imaging platforms enabling rapid and accurate spatial phenotyping at scale. You’ll also get a sneak peek at new spatial signature panels powered by a novel, universal chemistry that allows you to move seamlessly from high-plex spatial phenotyping assays for discovery on the PhenoCycler-Fusion to validate the resulting biomarkers on the Fusion, as a standalone system, at a capacity of 100+ samples per week.

What you will learn

• How the PhenoImager Fusion enables the development of more relevant and highly predictive biomarkers, called spatial phenotypic signatures
• How Multispectral Imaging (MSI) technology leads to quantitative and accurate phenotyping
• How our universal antibody chemistry promotes a seamless continuum from Discovery to Translational Research